AndexXa

AZ notches postmarket win for bleeding reversal agent Andexxa, plans to seek full approval
Fierce Pharma
Mon, 06/5/23 - 09:55 pm
AstraZeneca
bleeding reversal
AndexXa
Alexion Pharma to Buy Portola for $18-Share, or $1.41 Billion
TheStreet.com
Tue, 05/5/20 - 11:08 am
Alexion
M&A
Portola Pharmaceuticals
AndexXa
Portola's stock falls on weak Andexxa sales
Marketwatch
Sat, 01/11/20 - 11:20 pm
Portola Pharmaceuticals
AndexXa
earnings
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Fierce Pharma
Wed, 01/2/19 - 11:38 am
Portola Pharmaceuticals
AndexXa
Pfizer
Bristol-Myers Squibb
JNJ
Bayer
FDA
anticoagulant reversal
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Mon, 12/31/18 - 11:57 am
Goldman Sachs
Portola Pharmaceuticals
AndexXa
Sesen Bio
Vicinium
FDA Approval of Portola Drug Puts Firm in Line for $100M Payday
Xconomy
Fri, 05/4/18 - 06:50 pm
anticoagulant reversal
FDA
Portola Pharmaceuticals
AndexXa
In a comeback, Portola scores FDA accelerated approval for once-rejected Andexxa
Endpoints
Fri, 05/4/18 - 10:13 am
FDA
Portola Pharmaceuticals
andexanet alfa
AndexXa
blood thinners
3 Small-Cap Biotech Stocks With Big Catalysts in May
Motley Fool
Mon, 04/30/18 - 09:16 pm
Achaogen
plazomicin
Akcea Therapeutics
Volanesorsen
Portola Pharmaceuticals
AndexXa
Take two: Portola's reversal agent secures FDA review
BioPharma Dive
Wed, 08/16/17 - 10:14 am
Portola Pharmaceuticals
FDA
AndexXa
anticoagulant reversal